Reps. Gallagher and Pocan invite you to a briefing on
The Value of the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) for those with Neurofibromatosis (NF)
Friday January 11, 2019
2212 Rayburn House Office Building
Currently, there are no effective treatments and no cure for neurofibromatosis (NF), a genetic disorder affecting 1 in 3,000 people. Through research conducted by the NF Research Program within the CDMRP, research at the National Institutes of Health (NIH), and other public and private research partnerships, we know we will find solutions for NF patients as well as 175 million Americans suffering from traumatic brain injury, cognitive delays, various cancers, persistent pain, nerve damage and amputations.
Please join us for a briefing in collaboration with the Littlest Tumor Foundation on the value of the CDMRP to finding treatments for NF and other deadly diseases.
Dr. Roger Packer, MD, Children's National Medical Center
Renie Moss, NF Parent
Gregg Erickson, NF Network
Naba Bora, Ph.D., CDMRP-NFRP, DoD
Dr. Andrea Gross, MD, National Cancer Institute
Jill A. Morris, Ph.D., Program Director, Nuerogenetics National Institute of Neurological Disorders and Stroke, NIH
Annette Bakker, Ph.D., President and Chief Scientific Officer, Children's Tumor Foundation
When: Friday, January 11, 2019
Where: 2212 Rayburn House Office Building
Refreshments will be served. We look forward to seeing you there.
Member of Congress